Detalle de: CBD: A New Hope?
| Title | CBD: A New Hope? |
| Abstract |
The nonpsychoactive phytocannabinoid, CBD, was recently approved by the Food and Drug Administration for the treatment of children with drug-resistant epilepsy. This milestone opens new avenues for cannabinoid research. In this Viewpoint, we provide an overview of recent progress in the field highlighting molecular insights into CBD's mechanism of action, as well as its therapeutic potential. |
| Apa Reference | Morales, P. & Reggio, P.H. (2019). CBD: A New Hope?. ACS Medicinal Chemistry Letters, 10(5), 694-695. 10.1021/acsmedchemlett.9b00127 |
| Doi | 10.1021/acsmedchemlett.9b00127 |
| Publication Date | 29 Apr 2019 |
| Publication Type | Article |
| Researcher | Paula Morales |
| Ontology | Structure-function relationship, Drug resistance |
| Research Groups | |
| Tools |